Strides Arcolab soars on Pfizer deal

Image
BS Reporter Mumbai
Last Updated : Jan 21 2013 | 1:24 AM IST

 Strides Arcolab ended the day at Rs 254, stronger by Rs 19 or 8.2%, on the BSE.

The stock opened at Rs 245 and touched a new 52-week high of Rs 269 and a low of Rs 245 during the day.

There was a huge surge in volumes, with 8.72 lakh shares being traded on the counter as against the two-week average of 0.65 lakh shares.

Pfizer also had a good day, ending up by Rs 9 or 1% at Rs  951.

-------------------------------------------------------------------------------------------------------------------

(Updated at 0951 am)

Also Read

Strides Arcolab has soared on a collaboration with Pfizer, USA. Pfizer will commercialise around 40 off-patent products in the oncology area.

The stock opened at Rs 245 and jumped 14.5% to touch a new 52-week high of Rs 269. It is currently trading with a gain of Rs 24, or 10%, at Rs 259.

The stock has soared 332% from its 52 week low of Rs 60. The counter has seen comparatively hefty trade volumes of 3.82 lakh shares on the BSE, as against the two-week daily average trade of 65,000 shares.

Pfizer is also up 3.2% at Rs 972. The stock opened at Rs 950 and touched a high of Rs 991 - up 5.2% from the previous close. Over 5,719 shares have changed hands on the counter in BSE, as against the two-week daily average trade of 3,206 shares.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 07 2010 | 4:08 PM IST

Next Story